Who has invested in Solve Therapeutics?

Yosemite, Abingworth, Merck, Alexandria Venture Investments, Surveyor Capital, Citadel are named among the investors backing Solve Therapeutics.

Solve Therapeutics Funding: $120M Raised, Series A (2021)

Solve Therapeutics funding overview

Solve Therapeutics is a Biotech company based in San Diego, California. Solve Therapeutics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Solve Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Yosemite, Abingworth, Merck, Alexandria Venture Investments, Surveyor Capital, Citadel. 6 distinct backers are named across the disclosed rounds.

Solve Therapeutics at a glance

Total raised: $120M
Latest round: Series A
Latest round date: January 2021
Industry: Biotech
Headquarters: San Diego, California
Notable investors: Yosemite, Abingworth, Merck, Alexandria Venture Investments, Surveyor Capital, Citadel

Frequently asked about Solve Therapeutics funding

How much has Solve Therapeutics raised?: Solve Therapeutics has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Solve Therapeutics?: Yosemite, Abingworth, Merck, Alexandria Venture Investments, Surveyor Capital, Citadel are named among the investors backing Solve Therapeutics.
What was the latest Solve Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2021.
Where is Solve Therapeutics based?: Solve Therapeutics is based in San Diego, California.
What sector does Solve Therapeutics operate in?: Solve Therapeutics is tracked under Biotech from San Diego, California, with $120M in disclosed funding.
When did Solve Therapeutics last raise?: The last disclosed Solve Therapeutics round closed in January 2021 at Series A.

Solve Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Diego below to benchmark round size and investor mix.

Solve Therapeutics Funding: $120M Raised, Series A (2021)

Solve Therapeutics funding overview

Solve Therapeutics at a glance

Frequently asked about Solve Therapeutics funding

Companies related to Solve Therapeutics (38)

Browse related funding lists (9)